We are live on
!
Find out more
State Street SPDR S&P Biotech ETF
812 hedge funds and large institutions have $16.5B invested in State Street SPDR S&P Biotech ETF in 2025 Q4 according to their latest regulatory filings, with 230 funds opening new positions, 232 increasing their positions, 204 reducing their positions, and 53 closing their positions.
New
Increased
Maintained
Reduced
Closed
334% more first-time investments, than exits
New positions opened: 230 | Existing positions closed: 53
33% more capital invested
Capital invested by funds: $12.4B → $16.5B (+$4.06B)
24% more funds holding
Funds holding: 655 → 812 (+157)
14% more repeat investments, than reductions
Existing positions increased: 232 | Existing positions reduced: 204
6% more funds holding in top 10
Funds holding in top 10: 18 → 19 (+1)
15.4% less ownership
Funds ownership: 214.61% → 199.2% (-15%)
51% less call options, than puts
Call options by funds: $3.12B | Put options by funds: $6.42B
Holders
812
Holders Change
+157
Holders Change %
+23.97%
% of All Funds
9.88%
Holding in Top 10
19
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+5.56%
% of All Funds
0.23%
New
230
Increased
232
Reduced
204
Closed
53
Calls
$3.12B
Puts
$6.42B
Net Calls
-$3.31B
Net Calls Change
-$2.53B
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$1.22B |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$391M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
+$241M |
| 4 |
Two Sigma Investments
New York
|
+$201M |
| 5 |
Citigroup
New York
|
+$188M |
